Tornier And BioSET Enter Synthetic Growth Factor Pact

Published: Feb 06, 2008

EDINA, Minn.--(BUSINESS WIRE)--Tornier, Inc., a global leader in extremities orthopedics, announced today that it has entered into an exclusive world-wide technology collaboration in the field of orthopedic soft tissue repair with BioSurface Engineering Technologies, Inc. ("BioSET") to develop, commercialize, and distribute products that will incorporate BioSET’s synthetic growth factor technology. The collaboration will focus initially on ligament and tendon repair products that will feature coatings based on BioSET’s proprietary F2A synthetic growth factor technology (“F2A”).

Back to news